4DMedicalFDMDF -6.67%46 3-Year EBITDA Growth Rate is 11.80% as of Dec. 2025. GuruFocus rates FDMDF with a GF Score™ of 46/100 and a GF Value™ of $0.87 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 694 Medical Devices & Instruments companies, 4DMedical ranks better than 54.18% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 11.80% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -2.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of 4DMedical was 11.80% per year. The lowest was -3.70% per year. And the median was -1.40% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
4DMedical 3-Year EBITDA Growth Rate Related Terms
FDMDF vs ABT, SYK, MDT: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, 4DMedical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4DMedical 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where 4DMedical's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 11.80% mean?
4DMedical (FDMDF) has a 3-Year EBITDA Growth Rate of 11.80% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for 4DMedical and its competitors. According to the industry distribution chart, 4DMedical ranks #318 out of 694 companies in the Medical Devices & Instruments industry, placing it in the top 45.8%.
Is 4DMedical's 3-Year EBITDA Growth Rate too high?
4DMedical's current 3-Year EBITDA Growth Rate is 11.80%. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 7.65. 4DMedical's value of 11.80% is 54.2% above this industry median. Based on the distribution chart, 4DMedical ranks #318 out of 694 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, 4DMedical has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's 3-Year EBITDA Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 4DMedical ranks #318 out of 694 companies for 3-Year EBITDA Growth Rate. This puts 4DMedical in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 7.65. 4DMedical's value of 11.80% is 54.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 7.65, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 4DMedical's current 3-Year EBITDA Growth Rate of 11.80% is 54.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for 4DMedical and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 7.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4DMedical's current 3-Year EBITDA Growth Rate is 11.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (FDMDF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $2.80 — trading 221.8% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 11.80% and 54.2% above the Medical Devices & Instruments industry median of 7.65. 4DMedical's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For 4DMedical (FDMDF), the current 3-Year EBITDA Growth Rate is 11.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 4DMedical (FDMDF) Overvalued in 2026?
Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued.
The current stock price of $2.80 is trading 221.8% above its estimated GF Value™ of $0.87.
GuruFocus considers 4DMedical to be Significantly Overvalued.
Key valuation signals for FDMDF:
3-Year EBITDA Growth Rate: 11.80%
GF Value™: $0.87 vs. price of $2.80 (221.8% above fair value)
Industry Position: 54.2% above the Medical Devices & Instruments median (#318 of 694)
No single metric tells the full story. See the FDMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
46GF Score
Get the complete analysis for FDMDF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FDMDF has been successfully added to your 